N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

5.90p
   
  • Change Today:
      0.100p
  • 52 Week High: 5.96
  • 52 Week Low: 0.43
  • Currency: UK Pounds
  • Shares Issued: 101.46m
  • Volume: 581,138
  • Market Cap: 5.99m
2016-10-17 - Suspension of Listing

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2028.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 85.5 59.9
Pr/Book 6.8  
Latest F'cast
Revenue -36.4% 42.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

N4 Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (0.01) (0.86)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (0.16) (9.08)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (0.19) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.11 (1.93) (1.26)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.07 (1.39) (1.32)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

N4 Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.10 n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-20 0.10 n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

N4 Pharma Company Announcements

Second Price Monitoring Extn 15-Jul-2019 14:05 RNS
Price Monitoring Extension 15-Jul-2019 14:00 RNS
Second Price Monitoring Extn 03-Jul-2019 16:40 RNS

Latest N4 Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 5.90p
Change Today 0.100p
% Change 1.72 %
52 Week High 5.96
52 Week Low 0.43
Volume 581,138
Shares Issued 101.46m
Market Cap 5.99m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.7% below the market average47.7% below the market average47.7% below the market average47.7% below the market average47.7% below the market average
72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average
Value
47.7% below the market average47.7% below the market average47.7% below the market average47.7% below the market average47.7% below the market average
72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average
Income Not Available
Growth
22.35% below the market average22.35% below the market average22.35% below the market average22.35% below the market average22.35% below the market average
28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average

N4 Pharma Dividends

No dividends found

Trades for 19-Jul-2019

Time Volume / Share Price
15:45 45,729 @ 5.94p
13:01 16,585 @ 5.96p
12:43 42,724 @ 5.69p
12:35 100,000 @ 5.70p
12:13 17,438 @ 5.70p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page